Form 8-K - Current report:
SEC Accession No. 0001437749-22-012349
Filing Date
2022-05-13
Accepted
2022-05-13 16:05:30
Documents
13
Period of Report
2022-05-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20220512_8k.htm   iXBRL 8-K 32424
  Complete submission text file 0001437749-22-012349.txt   164783

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nby-20220511.xsd EX-101.SCH 3594
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20220511_def.xml EX-101.DEF 11530
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20220511_lab.xml EX-101.LAB 15415
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20220511_pre.xml EX-101.PRE 11686
7 EXTRACTED XBRL INSTANCE DOCUMENT nby20220512_8k_htm.xml XML 2567
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 22922635
SIC: 2834 Pharmaceutical Preparations